226 related articles for article (PubMed ID: 2908527)
1. Human T-cell immunity against Bordetella pertussis analyzed at clonal level.
Tagliabue A; De Magistris MT; Rappuoli R
Tokai J Exp Clin Med; 1988; 13 Suppl():253-7. PubMed ID: 2908527
[TBL] [Abstract][Full Text] [Related]
2. Human T cell immunity against Bordetella pertussis analyzed at clonal level.
De Magistris MT; Rappuoli R; Tagliabue A
Ann Ist Super Sanita; 1991; 27(1):33-6. PubMed ID: 1683526
[TBL] [Abstract][Full Text] [Related]
3. Dissecting human T cell responses against Bordetella species.
De Magistris MT; Romano M; Nuti S; Rappuoli R; Tagliabue A
J Exp Med; 1988 Oct; 168(4):1351-62. PubMed ID: 2902185
[TBL] [Abstract][Full Text] [Related]
4. The cellular immune response to Bordetella pertussis in two children with whooping cough.
Hafler JP; Pohl-Koppe A
Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
[TBL] [Abstract][Full Text] [Related]
5. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M; Nagai M
Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
[TBL] [Abstract][Full Text] [Related]
7. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
Sato H; Sato Y
Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
[TBL] [Abstract][Full Text] [Related]
9. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model.
Marr N; Oliver DC; Laurent V; Poolman J; Denoël P; Fernandez RC
Vaccine; 2008 Aug; 26(34):4306-11. PubMed ID: 18582518
[TBL] [Abstract][Full Text] [Related]
10. Acellular Bordetella pertussis vaccine enhances mucosal interleukin-10 production, induces apoptosis of activated Th1 cells and attenuates colitis in Galphai2-deficient mice.
Ohman L; Willén R; Hultgren OH; Hultgren Hörnquist E
Clin Exp Immunol; 2005 Jul; 141(1):37-46. PubMed ID: 15958068
[TBL] [Abstract][Full Text] [Related]
11. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
Alonso S; Pethe K; Mielcarek N; Raze D; Locht C
Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
[TBL] [Abstract][Full Text] [Related]
12. [Acellular pertussis vaccine].
Wiedermann G; Ambrosch F; Vanura H
Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820
[TBL] [Abstract][Full Text] [Related]
13. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
Prince HE; Lapé-Nixon M; Matud J
Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Bordetella pertussis filamentous hemagglutinin with human TLR2: identification of the TLR2-binding domain.
Asgarian-Omran H; Amirzargar AA; Zeerleder S; Mahdavi M; van Mierlo G; Solati S; Jeddi-Tehrani M; Rabbani H; Aarden L; Shokri F
APMIS; 2015 Feb; 123(2):156-62. PubMed ID: 25353353
[TBL] [Abstract][Full Text] [Related]
16. Engineering bacterial toxin for the development of new vaccine against pertussis.
Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
[TBL] [Abstract][Full Text] [Related]
17. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
David S; van Furth R; Mooi FR
Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
[TBL] [Abstract][Full Text] [Related]
18. Serological responses to infection with B. pertussis.
Giammanco A; Taormina S; Genovese M; Mangiaracina G; Giammanco G; Chiarini A
Dev Biol Stand; 1997; 89():213-20. PubMed ID: 9272353
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
Ausiello CM; Lande R; Urbani F; Di Carlo B; Stefanelli P; Salmaso S; Mastrantonio P; Cassone A
J Infect Dis; 2000 Jun; 181(6):1989-95. PubMed ID: 10837180
[TBL] [Abstract][Full Text] [Related]
20. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
